Paying Attention to Attention-Deficit/Hyperactivity Disorder Medications and Cardiovascular Risk

被引：0
|
作者：
Ziegelstein, Roy C. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JAMA NETWORK OPEN | 2022年 / 5卷 / 11期
关键词：
D O I：
10.1001/jamanetworkopen.2022.43606
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Paying Attention to Attention-Deficit/Hyperactivity Disorder
    Dickstein, Daniel P.
    JAMA NETWORK OPEN, 2018, 1 (04)
  • [2] Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder
    Jose Martinez-Raga
    Carlos Knecht
    Nestor Szerman
    María I. Martinez
    CNS Drugs, 2013, 27 : 15 - 30
  • [3] Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder
    Martinez-Raga, Jose
    Knecht, Carlos
    Szerman, Nestor
    Martinez, Maria I.
    CNS DRUGS, 2013, 27 (01) : 15 - 30
  • [4] Paying attention (Attention-Deficit/Hyperactivity Disorder and drug therapy)
    Rapley, M
    McHoul, A
    MEANJIN, 2004, 63 (04): : 60 - 67
  • [5] Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
    Zhang, Le
    Li, Lin
    Andell, Pontus
    Garcia-Argibay, Miguel
    Quinn, Patrick D.
    D'Onofrio, Brian M.
    Brikell, Isabell
    Kuja-Halkola, Ralf
    Lichtenstein, Paul
    Johnell, Kristina
    Larsson, Henrik
    Chang, Zheng
    JAMA PSYCHIATRY, 2024, 81 (02) : 178 - 187
  • [6] Cardiovascular Safety of Stimulant Medications for Pediatric Attention-Deficit Hyperactivity Disorder
    Silva, Raul R.
    Skimming, Jeffrey W.
    Muniz, Rafael
    CLINICAL PEDIATRICS, 2010, 49 (09) : 840 - 851
  • [7] Attention: Attention-deficit/hyperactivity disorder
    Shulman, Stanford T.
    PEDIATRIC ANNALS, 2008, 37 (01): : 5 - 6
  • [8] CURRENT MEDICATIONS FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Vaughan, Brigette S.
    Roberts, Holly J.
    Needelman, Howard
    PSYCHOLOGY IN THE SCHOOLS, 2009, 46 (09) : 846 - 856
  • [9] Attention-deficit disorder (attention-deficit/hyperactivity disorder without hyperactivity): A neurobiologic ally and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity)
    Diamond, A
    DEVELOPMENT AND PSYCHOPATHOLOGY, 2005, 17 (03) : 807 - 825
  • [10] Medications for attention deficit hyperactivity disorder: cardiovascular concerns
    Wooltorton, E
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (01) : 29 - 30
12345